A scientific commentary published in the Journal of Cancer Research and Clinical Oncology evaluates the therapeutic conclusions of an earlier paper investigating TTK inhibition in lung adenocarcinoma. Authored by Ehsan Khodamoradi, the Matters Arising article directly addresses an October 2026 study by Patidar and colleagues concerning TTK-mediated ceRNA networks in lung adenocarcinoma.
The commentary identifies two critical scientific issues that were not addressed in the original paper’s limitations section. First, Khodamoradi points out that Patidar and colleagues interpreted molecular docking scores as evidence of binding affinity and inhibitory activity in their study. The commentary explains that interpreting in silico docking scores as evidence of binding affinity or inhibitory activity is scientifically unsupported.
Second, the commentary emphasizes that the original therapeutic recommendation for hesperidin lacks any functional validation. According to Khodamoradi, the authors did not perform any enzymatic, cellular, or in vivo assays to support their claims. Without functional experimental testing, in silico docking observations cannot establish whether hesperidin provides actual therapeutic efficacy against TTK.
Overall, the commentary reiterates that docking scores do not establish binding affinity or therapeutic efficacy regarding TTK inhibition in lung adenocarcinoma. Because no functional assays were performed to evaluate hesperidin, Khodamoradi concludes that these unaddressed scientific concerns fundamentally affect the validity of the paper’s therapeutic conclusions and warrant clarification.
Subject of Research: Critique of in silico docking scores and therapeutic conclusions in lung adenocarcinoma
Article Title: Docking scores do not establish binding affinity or therapeutic efficacy: concerns regarding the interpretation of in silico findings on TTK inhibition in lung adenocarcinoma
Article References: Khodamoradi, E. (2026). Docking scores do not establish binding affinity or therapeutic efficacy: concerns regarding the interpretation of in silico findings on TTK inhibition in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology, 152(12), Article 237. https://doi.org/10.1007/s00432-026-06657-9
Image Credits: AI Generated
DOI: 10.1007/s00432-026-06657-9
Keywords: TTK inhibition, lung adenocarcinoma, molecular docking, binding affinity, therapeutic efficacy, in silico findings, hesperidin, ceRNA networks, functional validation, enzymatic assays, cellular assays, in vivo assays, Matters Arising, Ehsan Khodamoradi, Journal of Cancer Research and Clinical Oncology, inhibitory activity, Patidar
News Source: Nathaniel Bowman. (November 19, 2026). Docking Scores Do Not Establish Binding Affinity in Lung Adenocarcinoma Study. Scienmag.



